IT’S AN ACQUISITION THAT BRINGS TOGETHER two different gene sequencing technologies into one firm. On Nov. 1, Illumina, Inc., announced an agreement to acquire Pacific Biosciences (PacBio) for $1.2 billion. This deal will bolster Illumina’s already-dominant position in the market for DNA-sequencing machines. Wall Street analysts quickly pointed out that this gives Illumina control of two […]
- IVD Sector Update
Illumina to Pay $1.2 Billion to Acquire Pacific Biosciences
Deal gives Illumina ownership of two different technologies for sequencing whole human genomes
- By Joseph Burns
- > From the Volume XXV No. 17 - December 3, 2018 Issue
